SB
Saroja Basanagouda Karegoudar
About Saroja Basanagouda Karegoudar
Data last updated:
Saroja Basanagouda Karegoudar is a Director at Qromed Remedies Private Limited (since 2019) and Designated Partner at Nuzen Innovations Llp (since 2022). The companies operate in Pharma and Home Appliances. The largest current company by reported revenue is Qromed Remedies Private Limited at ₹2.36 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Qromed Remedies Private Limited U24290KA2018PTC110128 | Director | 07 Mar 2019 | 2018 | ₹2.36 Cr (FY 2024) | Active |
| Nuzen Innovations Llp ABZ-4996 | Designated Partner | 17 Dec 2022 | 2022 | Active |
Board colleagues of Saroja Basanagouda Karegoudar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Saroja Basanagouda Karegoudar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saroja Basanagouda Karegoudar
Saroja Basanagouda Karegoudar currently holds 2 directorships: Qromed Remedies Private Limited (Director, since 07 Mar 2019, revenue ₹2.36 Cr (FY 2024)); Nuzen Innovations Llp (Designated Partner, since 17 Dec 2022).
Saroja Basanagouda Karegoudar was first appointed on 07 Mar 2019 as Director at Qromed Remedies Private Limited. The most recent appointment on record is 17 Dec 2022 at Nuzen Innovations Llp.
The current boards of Saroja Basanagouda Karegoudar's companies include Ajit Venkappa Kanakaraddi (Qromed Remedies Private Limited), Balakrishna Devendrappa Sakhare (Qromed Remedies Private Limited), Basanagouda Tirakanagouda Karegoudar (Qromed Remedies Private Limited), Chidanand Mohan Mudkavi (Qromed Remedies Private Limited), Gadigeppa Nagappa Sanadi (Qromed Remedies Private Limited), Girish Pralhadrao Kulkarni (Qromed Remedies Private Limited), among others.